Marked Chart Marked Chart Open

The Marked Chart Wire · Series of events

Series of events · Lung Cancer

Lung Cancer: the latest, in order

3 stories from Sat to Mon, newest last.

3 eventsSat to MonAMGN+0.3%AZN-0.2%MRK-3.0%LLY+0.5%

Updated

What happened, in order

Times are Eastern

  1. Where it began

    Amgen therapy lowers mortality risk

    Amgen therapy lowers mortality risk in severe lung disease

    Read the story

  2. Merck and Lilly share new

    Merck and Lilly share new lung cancer combination data

    Read the story

  3. Latest

    Hutchmed reports Safron trial results

    Hutchmed reports Safron trial results for lung cancer drug combo

    Read the story

The stocks in this series

  1. AMGN+0.3%Amgen$440.42
  2. AZN-0.2%AstraZeneca$171.11
  3. MRK-3.0%Merck$140.91
  4. LLY+0.5%Eli Lilly$1,279

Prices from Live · updated 1:31 PM ET. Each tile opens the stock's chart and news.

All series of events

A series is a short summary of connected news, for learning. Not verified and not advice. Check the full stories before you act.